Results 321 to 330 of about 195,645 (350)
The role of oxidative stress-related genes in idiopathic pulmonary fibrosis. [PDF]
Sci RepZhao W +7 more
europepmc +1 more source
Polygenic risk of idiopathic pulmonary fibrosis and COVID-19 severity. [PDF]
ERJ Open ResGuillen-Guio B +11 more
europepmc +1 more source
Idiopathic Pulmonary Fibrosis. [PDF]
New England Journal of Medicine, 2018 Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis appears to be increasing in incidence. It requires early recognition and intervention with supportive care and pharmacologic agents to forestall its progression.
D. Lederer, F. Martinez
semanticscholar +9 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Idiopathic pulmonary fibrosis: state of the art for 2023
European Respiratory Journal, 2023Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by worsening respiratory symptoms and physiological impairment.
A. Podolanczuk +6 more
semanticscholar +1 more source
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis.
Annual Review of Pathology, 2021The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in the context of predisposing factors (e.g., genetic, environmental ...
B. Moss, S. Ryter, I. Rosas
semanticscholar +1 more source
Seminars in Respiratory and Critical Care Medicine, 2012
Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive, chronic fibrosing interstitial lung disease occurring primarily in older adults and limited to the lungs. The prognosis is dire, with half of all patients progressing to death from respiratory failure within 3 to 5 years from initial diagnosis. The pathogenesis of IPF is complex and
Jessica M. Adkins, Harold R. Collard
openaire +5 more sources
Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive, chronic fibrosing interstitial lung disease occurring primarily in older adults and limited to the lungs. The prognosis is dire, with half of all patients progressing to death from respiratory failure within 3 to 5 years from initial diagnosis. The pathogenesis of IPF is complex and
Jessica M. Adkins, Harold R. Collard
openaire +5 more sources
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine, 2018Background: This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society ...
G. Raghu +33 more
semanticscholar +1 more source
Annual Review of Medicine, 1993
Idiopathic pulmonary fibrosis kills half of its victims within five years of diagnosis. Currently available treatment regimens are disappointing, and the incidence of the disease appears to be increasing. Newer techniques of imaging coupled with laboratory advances in molecular and cellular biology may produce new strategies for modulating the disease ...
Owen J, Dempsey, David, Miller
openaire +3 more sources
Idiopathic pulmonary fibrosis kills half of its victims within five years of diagnosis. Currently available treatment regimens are disappointing, and the incidence of the disease appears to be increasing. Newer techniques of imaging coupled with laboratory advances in molecular and cellular biology may produce new strategies for modulating the disease ...
Owen J, Dempsey, David, Miller
openaire +3 more sources
American Journal of Respiratory and Critical Care Medicine, 2015
BACKGROUND This document updates the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on idiopathic pulmonary fibrosis treatment.
G. Raghu +20 more
semanticscholar +1 more source
BACKGROUND This document updates the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on idiopathic pulmonary fibrosis treatment.
G. Raghu +20 more
semanticscholar +1 more source